Stephens Consulting’s CRISPR Therapeutics CRSP Stock Holding History

Stephens Consulting’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$649	Hold
2025 Q2	$487	Hold
2025 Q1	$341	Hold
2024 Q4	$394	Hold
2024 Q3	$470	Buy